A safe-haven stock with big dividends that I’d buy for my ISA

Expect financial market volatility to remain in play in the coming months, says Royston Wild. He explains why this safe haven is a great ISA buy today.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With financial markets set to remain volatile for some time yet, loading up on stable safe-haven stocks continues to be a good idea. Assura (LSE: AGR) is one such share I’d happily stash my ISA cash into.

Healthcare stocks are some of those most popular targets when the economy is beginning to flag. We still need drugs and critical medical services irrespective of whatever troubles are raging outside our windows. And as a creator and manager of general practitioner (or GP) surgeries and other primary healthcare facilities, this particular FTSE 250 stock is a wise buy for ISA investors in these troubled times. News in early April that “March quarter rents [are] being received in line with normal patterns” underlined the robustness of the company’s operations.

Don’t think of Assura as a stodgy defensive pick, though. Through its aggressive expansion policy, it’s putting itself in the box seat to capitalise on the UK’s ageing population and turbocharge profits growth. A mix of acquisition activity and new developments meant that it had 576 properties on its books as of December. This represented an increase of 13 from end of 2018.

Estimates show that half of Britain’s GP surgeries are not fit for purpose. The demand outlook for Assura’s state-of-the-art properties looks quite bright for the next few decades then.

A perky pipeline

Now, the Covid-19 outbreak threatens to put the brakes on Assura’s grand plans. In last month’s update, the healthcare firm advised that it is following government lockdown advice concerning its construction sites. And as a consequence, it said that it’s “prepared for delays to anticipated completion dates for our on-site developments and start dates of the immediate pipeline.”

This is a mere hindrance to the FTSE 250 firm’s growth strategy, of course, rather than a critical development. In fact Assura’s pipeline remains quite mighty. On the acquisition side, its immediate pipeline stands at £67m, while its corresponding development pipeline sits at £77m. It’s in great shape to keep expanding its estate once lockdown measures are eased.

What’s more, a recent share placing saw the property giant raise £185m last month. The move gives it scope to transact an extra £250m of property additions before the group’s loan-to-value level hits the 40% marker, a level that could see its corporate rating take a hit.

A terrific ISA buy

In the meantime, City analysts expect the healthcare play to grow annual earnings by single-digit percentages. They forecast rises of 1% and 6% for the fiscal years to March 2021 and 2022 respectively. Predictions of more profits growth underpin expectations of more dividend growth too. Thus yields sit at a chunky 3.7% and 3.9% for this year and next.

Assura commands a princely premium at current prices around 80p. A price-to-earnings (P/E) ratio of 28 times illustrates this point. But don’t turn your nose up. I reckon the firm’s safe-haven qualities, coupled with its exciting growth strategy, merit a hefty price tag. I’d happily add it to my own ISA.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »